Company Filing History:
Years Active: 2020
Title: Waleed Haso: Innovator in Cancer Treatment
Introduction
Waleed Haso is a prominent inventor based in Boston, MA, who has made significant contributions to the field of cancer treatment. His innovative work focuses on developing advanced therapeutic techniques that target specific cancer cells.
Latest Patents
Waleed Haso holds a patent for "Dual specific anti-CD22-anti-CD19 chimeric antigen receptors." This invention provides dual specific chimeric antigen receptors (CARs) that have antigenic specificity for CD19 and CD22. The patent includes nucleic acids, recombinant expression vectors, host cells, populations of cells, and pharmaceutical compositions related to the CARs. Additionally, it discloses methods for detecting the presence of cancer in mammals and methods for treating or preventing cancer in mammals.
Career Highlights
Waleed Haso is affiliated with the National Institutes of Health, a component of the US Department of Health & Human Services. His work at this esteemed institution allows him to collaborate with leading experts in the field of cancer research and treatment.
Collaborations
Some of Waleed Haso's notable coworkers include Terry J Fry and Crystal L Mackall. Their collaborative efforts contribute to advancing cancer therapies and improving patient outcomes.
Conclusion
Waleed Haso's innovative contributions to cancer treatment through his patented technology exemplify the potential of targeted therapies in modern medicine. His work continues to inspire advancements in the fight against cancer.